Résultats de recherche

Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy which positions us for long-term success by focusing together for patients and society. Four priorities will drive continued growth and bring transformative medicines to...

October is Liver Cancer Awareness Month and this year we are proud to be supporting the European Liver Patients Association (ELPA) with their campaign encouraging everyone to rethink liver cancer by bringing it to the forefront of conversations....

Octobre est le mois de la sensibilisation au cancer du foie. Cette année, nous sommes fiers de soutenir à nouveau la campagne de la European Liver Patients Association (ELPA), qui vise à porter un autre regard sur le cancer du foie en le plaç...

The facts and figures around breast cancer bring into focus the importance of raising awareness of the true scale of this globally prevalent disease. Breast cancer is the most common cancer in women1. It comprises of 24% of all cancers diagnosed in women2 ...

Les chiffres du cancer du sein font prendre conscience de l’importance de communiquer sur l’ampleur de cette maladie dans le monde. Le cancer du sein est le cancer le plus fréquent chez la femme1 : il représente 25 % des diagnostics de canc...

We are pleased to announce the appointment of Bartek Bednarz, Executive Vice President Global Product & Portfolio Strategy and Patrice Zagame, Executive Vice President, Specialty Care International to the Executive Leadership Team (ELT), effective imme...

We are delighted to welcome David Loew as the new CEO of Ipsen. A seasoned professional, David’s career has spanned nearly thirty years in the pharmaceutical industry in such companies as Roche and Sanofi. His leadership skills and experience in a range ...